Lower demand hits Lonza's full-year sales
This article was originally published in Scrip
Executive Summary
Lower demand across all its businesses saw Swiss pharmaceutical ingredients supplier Lonza record sales of CHF2.69 billion (€1.83 billion) for 2009, down by 8% on the previous year.